Dwayne 'The Rock' Johnson has sent a heartfelt message to Davina McCall, who recently revealed she had been diagnosed with breast cancer after spotting a 'small lump'
(MedPage Today) -- After reviewing the positive findings in HER2-positive early-stage breast cancer from both DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) in an earlier video, investigator Erika Hamilton, MD, of the Sarah Cannon…
Researchers have identified a stress-activated control mechanism that helps breast cancer cells reshape gene activity to survive and grow. Cells often encounter environmental pressures that can harm or even kill them. To stay alive, they…
Davina McCall, a judge on The Masked Singer and presenter of My Mum, Your Dad, had brain surgery to remove a benign tumour in November last year and since then, found a lump in her breast
Researchers at the LSU LCMC Health Cancer Center have published groundbreaking findings in NPJ Breast Cancer that sheds new light on triple-negative breast cancer (TNBC), one of the most aggressive forms of breast cancer.
The iced tea chain’s most successful campaign yet funds comfort kits for patients undergoing breast cancer treatment, uniting customers and communities in support.
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel, Switzerland, have now discovered that it also fights metastases in…
Researchers at the LSU LCMC Health Cancer Center have published findings in npj Breast Cancer that shed new light on triple-negative breast cancer (TNBC), one of the most aggressive forms of breast cancer.
(MedPage Today) -- In resource-limited settings, genomic assays for hormone receptor-positive, HER2-negative breast cancer aren't always accessible. Yet treatment decisions still need to be made -- often quickly and with limited…
VANCOUVER, Washington, Nov. 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5…
NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that multiple abstracts on…